Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
NCT05507658
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Locally Advanced Gastric Adenocarcinoma
Interventions
DRUG:
Tislelizumab combined with Oxaliplatin and Capecitabine
Sponsor
Xijing Hospital